Beijing Scitop Bio-tech Temettü
Temettü kriter kontrolleri 2/6
Beijing Scitop Bio-tech is a dividend paying company with a current yield of 1% that is well covered by earnings.
Anahtar bilgiler
1.0%
Temettü verimi
-17.4%
Geri Alım Getirisi
Toplam Hissedar Getirisi | -16.4% |
Gelecekteki Temettü Verimi | 1.8% |
Temettü Büyümesi | -20.3% |
Bir sonraki temettü ödeme tarihi | n/a |
Eski temettü tarihi | n/a |
Hisse başına temettü | CN¥0.150 |
Ödeme oranı | 43% |
Son temettü güncellemeleri
Recent updates
Beijing Scitop Bio-tech Co., Ltd.'s (SZSE:300858) Earnings Haven't Escaped The Attention Of Investors
Sep 27Weak Statutory Earnings May Not Tell The Whole Story For Beijing Scitop Bio-tech (SZSE:300858)
Aug 27Beijing Scitop Bio-tech (SZSE:300858) Will Pay A Smaller Dividend Than Last Year
Jun 29Investor Optimism Abounds Beijing Scitop Bio-tech Co., Ltd. (SZSE:300858) But Growth Is Lacking
Apr 18Beijing Scitop Bio-tech (SZSE:300858) Is Reinvesting At Lower Rates Of Return
Mar 22Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: 300858 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Büyüyen Temettü: 300858 has only been paying a dividend for 3 years, and since then payments have fallen.
Piyasaya Karşı Temettü Getirisi
Beijing Scitop Bio-tech Piyasaya Karşı Temettü Getirisi |
---|
Segment | Temettü Verimi |
---|---|
Şirket (300858) | 1.0% |
Pazarın Alt %25'i (CN) | 0.6% |
Pazarın En İyi %25'i (CN) | 2.2% |
Sektör Ortalaması (Food) | 2.3% |
Analist tahmini (300858) (3 yıla kadar) | 1.8% |
Önemli Temettü: 300858's dividend (1%) is higher than the bottom 25% of dividend payers in the CN market (0.57%).
Yüksek Temettü: 300858's dividend (1%) is low compared to the top 25% of dividend payers in the CN market (2.22%).
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: With its reasonably low payout ratio (42.9%), 300858's dividend payments are well covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: 300858 is paying a dividend but the company has no free cash flows.